Biomerica Gains Egyptian Authorization For Full Portfolio Of Rapid Diagnostic Tests
I'm PortAI, I can summarize articles.
Biomerica, Inc. has received authorization from the Egyptian Drug Authority for its full portfolio of rapid diagnostic tests for cancers and chronic diseases. This includes at-home tests like the EZ Detect Colon Disease Test and Aware Breast Self Exam. Following the announcement, Biomerica's shares rose over 4% in pre-market trading.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: rttnews The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments